drugset / Trial / NCT04156568

A Multicentre, Cohort Study of Screening and Preventive Intervention for Latent Tuberculosis Infection in Children

NCT04156568 ↗

Phase 1 Unknown 1000 enrolled Beijing Children's Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The management of latent Mycobacterium tuberculosis infection is a new priority action for the WHO End Tuberculosis (TB) Strategy. However, national guidelines on latent tuberculosis infection testing and treatment have not yet been developed in children of China. Here, we present the results from the 3-year follow-up of a study that aimed to track the development of active disease in individuals with latent tuberculosis infection, identify priority populations for latent infection management, and explore the most suitable latent infection diagnostic approach.

Timeline

Start
2018-11-01
Primary completion
2021-09-01
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject INH Unknown 10 mg/kg —
Subject RFT Unknown 15 mg/kg —